Document Detail


Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.
MedLine Citation:
PMID:  17571194     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A series of indolequinones bearing a range of substituents at the (indol-2-yl)methyl position has been synthesized. The ability of these indolequinones to act as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumour cells, was determined, along with their toxicity to an isogenic tumour cell line pair that is differentiated as either NQO1-expressing cells (BE-NQ) or NQO1-null cells (BE-WT). Overall, the 2-substituted indolequinones were relatively poor substrates for NQO1. Hydroxymethyl groups at C-2 led to higher rates of reduction, a finding that was observed previously with 3-hydroxymethylated indolequinones. Predictably, the best substrate had an electron-withdrawing ester group at the indole-2-position. The indolequinones were generally non-toxic to both cell lines with the exception of those quinones that had methylaziridine groups at the indole-5-position. These compounds could form DNA cross-links when activated by reduction and were up to 3-fold more toxic to the BE-NQ cells than the BE-WT cells.
Authors:
Jeffery J Newsome; Elizabeth Swann; Mary Hassani; Kurtis C Bray; Alexandra M Z Slawin; Howard D Beall; Christopher J Moody
Related Documents :
7437594 - Tumour growth and cancer therapy.
10884734 - Changed delivery of boron to tumours using electroporation for boron neutron capture th...
9713474 - Sputum cells from lung tumor patients carry a cell surface marker not found in normal s...
1692164 - Human epithelial thymic tumours: heterogeneity in immunostaining of epithelial cell mar...
16293434 - Implications of oxidative stress in the cytotoxicity of pseudomonas aeruginosa exou.
11771894 - Fast-developing preimplantation embryo progeny from heterogametic females in mammals.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2007-04-20
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  5     ISSN:  1477-0520     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-06-15     Completed Date:  2007-08-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  1629-40     Citation Subset:  IM    
Affiliation:
Department of Chemistry, University of Exeter, Stocker Road, Exeter, UK EX4 4QD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / chemical synthesis*,  pharmacology
Cell Line, Tumor
Cross-Linking Reagents / pharmacology
Crystallography, X-Ray
DNA / chemistry
Drug Screening Assays, Antitumor
Electrons
Gene Expression Regulation, Neoplastic*
Humans
Indolequinones / pharmacology*
Models, Chemical
Molecular Conformation
NAD(P)H Dehydrogenase (Quinone) / metabolism*
Oxidation-Reduction
Quinones / chemistry
Grant Support
ID/Acronym/Agency:
P20 RR17670/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Cross-Linking Reagents; 0/Indolequinones; 0/Quinones; 9007-49-2/DNA; EC 1.6.5.2/NAD(P)H Dehydrogenase (Quinone)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis and studies of catechol-containing mycobactin S and T analogs.
Next Document:  Carbanion reactivity, kinetic and equilibrium studies of sigma-adduct formation and elimination in t...